| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetics, Medical | 8 | 2021 | 51 | 1.950 |
Why?
|
| Genetic Testing | 10 | 2018 | 565 | 1.160 |
Why?
|
| Chromosome Deletion | 9 | 2015 | 223 | 1.100 |
Why?
|
| Intellectual Disability | 7 | 2018 | 203 | 1.040 |
Why?
|
| Chromosome Disorders | 5 | 2015 | 100 | 0.960 |
Why?
|
| Developmental Disabilities | 7 | 2016 | 208 | 0.930 |
Why?
|
| Neonatal Screening | 5 | 2017 | 67 | 0.900 |
Why?
|
| Education, Medical | 2 | 2020 | 252 | 0.850 |
Why?
|
| Lysosomal Storage Diseases | 3 | 2017 | 11 | 0.840 |
Why?
|
| Internet | 3 | 2014 | 340 | 0.810 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 238 | 0.780 |
Why?
|
| Genomics | 6 | 2021 | 857 | 0.750 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2020 | 189 | 0.730 |
Why?
|
| Genetic Counseling | 4 | 2016 | 102 | 0.700 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 68 | 0.630 |
Why?
|
| Mosaicism | 3 | 2017 | 74 | 0.610 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 50 | 0.540 |
Why?
|
| Mutation | 15 | 2018 | 4374 | 0.490 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2016 | 8 | 0.480 |
Why?
|
| Seizures | 2 | 2015 | 331 | 0.460 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 45 | 0.440 |
Why?
|
| Infant, Newborn | 15 | 2017 | 2610 | 0.430 |
Why?
|
| Information Services | 1 | 2014 | 23 | 0.420 |
Why?
|
| Databases, Nucleic Acid | 1 | 2014 | 44 | 0.410 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2011 | 100 | 0.400 |
Why?
|
| Disclosure | 1 | 2014 | 111 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2010 | 128 | 0.400 |
Why?
|
| Gene Frequency | 4 | 2015 | 703 | 0.390 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 121 | 0.390 |
Why?
|
| Child, Preschool | 15 | 2018 | 3970 | 0.380 |
Why?
|
| Humans | 60 | 2021 | 95799 | 0.380 |
Why?
|
| Internship and Residency | 1 | 2021 | 1134 | 0.370 |
Why?
|
| Chromosomes, Human, Y | 2 | 2017 | 26 | 0.360 |
Why?
|
| Consensus | 1 | 2014 | 370 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2011 | 61 | 0.360 |
Why?
|
| Nuclear Proteins | 5 | 2018 | 750 | 0.350 |
Why?
|
| Infant | 15 | 2018 | 3360 | 0.350 |
Why?
|
| Growth Disorders | 3 | 2005 | 66 | 0.340 |
Why?
|
| Copper | 3 | 2000 | 81 | 0.340 |
Why?
|
| Chondrodysplasia Punctata | 2 | 2009 | 7 | 0.340 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 19 | 0.340 |
Why?
|
| Epilepsy | 1 | 2015 | 452 | 0.330 |
Why?
|
| Facies | 3 | 2013 | 29 | 0.320 |
Why?
|
| Membrane Proteins | 2 | 2016 | 1275 | 0.310 |
Why?
|
| Precision Medicine | 1 | 2014 | 454 | 0.300 |
Why?
|
| Vitamin K Deficiency | 1 | 2009 | 5 | 0.300 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 22 | 0.300 |
Why?
|
| Chromosome Mapping | 4 | 2013 | 1080 | 0.300 |
Why?
|
| Educational Measurement | 2 | 2021 | 246 | 0.290 |
Why?
|
| Databases, Genetic | 2 | 2009 | 284 | 0.290 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 1267 | 0.280 |
Why?
|
| Ataxia | 3 | 2018 | 47 | 0.280 |
Why?
|
| Gene Duplication | 2 | 2012 | 129 | 0.270 |
Why?
|
| Fetal Growth Retardation | 1 | 2008 | 72 | 0.270 |
Why?
|
| DiGeorge Syndrome | 1 | 2007 | 11 | 0.260 |
Why?
|
| Child | 16 | 2018 | 7618 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2005 | 396 | 0.260 |
Why?
|
| Hand Deformities, Congenital | 3 | 2005 | 15 | 0.260 |
Why?
|
| Fathers | 1 | 2008 | 82 | 0.250 |
Why?
|
| Genetic Linkage | 1 | 2008 | 620 | 0.250 |
Why?
|
| Female | 36 | 2018 | 49869 | 0.250 |
Why?
|
| Bariatric Surgery | 1 | 2009 | 207 | 0.240 |
Why?
|
| Syndrome | 9 | 2013 | 450 | 0.240 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 355 | 0.240 |
Why?
|
| Karyotyping | 3 | 2018 | 224 | 0.240 |
Why?
|
| Cation Transport Proteins | 2 | 2012 | 70 | 0.240 |
Why?
|
| Pyloric Stenosis | 1 | 2005 | 8 | 0.230 |
Why?
|
| Phenotype | 11 | 2018 | 2575 | 0.230 |
Why?
|
| Male | 30 | 2018 | 45685 | 0.230 |
Why?
|
| Clinical Competence | 2 | 2021 | 854 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2015 | 47 | 0.210 |
Why?
|
| Genome, Human | 3 | 2016 | 824 | 0.210 |
Why?
|
| Exome | 4 | 2018 | 141 | 0.210 |
Why?
|
| Genes, Recessive | 2 | 2015 | 86 | 0.200 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 555 | 0.200 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2003 | 5 | 0.200 |
Why?
|
| Ophthalmoplegia | 1 | 2003 | 12 | 0.200 |
Why?
|
| Chromosome Aberrations | 2 | 2018 | 353 | 0.200 |
Why?
|
| Pedigree | 8 | 2015 | 977 | 0.200 |
Why?
|
| Prions | 2 | 2000 | 52 | 0.190 |
Why?
|
| Superoxide Dismutase | 2 | 2000 | 156 | 0.190 |
Why?
|
| Computational Biology | 1 | 2006 | 586 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2008 | 365 | 0.180 |
Why?
|
| Curriculum | 3 | 2020 | 615 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 2474 | 0.170 |
Why?
|
| Certification | 1 | 2021 | 66 | 0.170 |
Why?
|
| Students, Medical | 1 | 2006 | 455 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2002 | 47 | 0.170 |
Why?
|
| Microarray Analysis | 2 | 2018 | 98 | 0.160 |
Why?
|
| Foot Deformities, Congenital | 1 | 2000 | 11 | 0.160 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2000 | 13 | 0.160 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2000 | 13 | 0.160 |
Why?
|
| Licensure, Medical | 1 | 2020 | 22 | 0.160 |
Why?
|
| Duodenal Diseases | 1 | 2000 | 25 | 0.160 |
Why?
|
| Electron Transport Complex IV | 1 | 2000 | 49 | 0.160 |
Why?
|
| Microcephaly | 1 | 2000 | 79 | 0.160 |
Why?
|
| Neurofibromatosis 1 | 1 | 2000 | 45 | 0.160 |
Why?
|
| Monosomy | 1 | 1999 | 12 | 0.150 |
Why?
|
| United States | 3 | 2021 | 7764 | 0.150 |
Why?
|
| Craniofacial Dysostosis | 1 | 1999 | 12 | 0.150 |
Why?
|
| Sequence Deletion | 2 | 2013 | 212 | 0.150 |
Why?
|
| Methylmalonic Acid | 1 | 1998 | 7 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2000 | 277 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1999 | 102 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 1999 | 58 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 564 | 0.140 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2018 | 15 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2018 | 34 | 0.140 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 29 | 0.140 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2017 | 8 | 0.140 |
Why?
|
| Phytosterols | 1 | 2017 | 6 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2018 | 78 | 0.140 |
Why?
|
| Chromosomes | 1 | 2018 | 96 | 0.140 |
Why?
|
| Ezetimibe | 1 | 2017 | 37 | 0.140 |
Why?
|
| Menkes Kinky Hair Syndrome | 2 | 2012 | 6 | 0.140 |
Why?
|
| Face | 1 | 2018 | 114 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2017 | 71 | 0.130 |
Why?
|
| Ovotesticular Disorders of Sex Development | 1 | 2017 | 4 | 0.130 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2017 | 11 | 0.130 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 85 | 0.130 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 161 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 2 | 2012 | 155 | 0.130 |
Why?
|
| Founder Effect | 2 | 2014 | 106 | 0.120 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2016 | 17 | 0.120 |
Why?
|
| Dental Enamel | 1 | 2016 | 16 | 0.120 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 153 | 0.120 |
Why?
|
| Estradiol | 1 | 2017 | 255 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2016 | 302 | 0.120 |
Why?
|
| Thiolester Hydrolases | 1 | 2016 | 16 | 0.120 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 49 | 0.120 |
Why?
|
| Fanconi Anemia | 1 | 2015 | 9 | 0.120 |
Why?
|
| Adult | 11 | 2018 | 28578 | 0.120 |
Why?
|
| Adolescent | 10 | 2018 | 9873 | 0.120 |
Why?
|
| Testosterone | 1 | 2017 | 276 | 0.120 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2015 | 5 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2015 | 52 | 0.110 |
Why?
|
| Trisomy | 2 | 2013 | 53 | 0.110 |
Why?
|
| Illinois | 2 | 2017 | 530 | 0.110 |
Why?
|
| Heart Defects, Congenital | 2 | 2010 | 380 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 547 | 0.110 |
Why?
|
| Genetic Research | 1 | 2014 | 18 | 0.110 |
Why?
|
| Genetic Carrier Screening | 1 | 2014 | 59 | 0.110 |
Why?
|
| Brain | 3 | 2015 | 2479 | 0.110 |
Why?
|
| Temporal Lobe | 1 | 2015 | 195 | 0.100 |
Why?
|
| Prenatal Diagnosis | 2 | 2012 | 110 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 540 | 0.100 |
Why?
|
| Desmocollins | 1 | 2013 | 3 | 0.100 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2013 | 10 | 0.100 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2013 | 15 | 0.100 |
Why?
|
| Movement Disorders | 1 | 2013 | 45 | 0.100 |
Why?
|
| Vesicular Transport Proteins | 1 | 2013 | 70 | 0.100 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.100 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 24 | 0.100 |
Why?
|
| Telomere | 2 | 2005 | 121 | 0.100 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2012 | 3 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2013 | 68 | 0.100 |
Why?
|
| Failure to Thrive | 1 | 2012 | 17 | 0.100 |
Why?
|
| Consanguinity | 2 | 2013 | 73 | 0.100 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2012 | 3 | 0.090 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2012 | 7 | 0.090 |
Why?
|
| New York | 1 | 2012 | 75 | 0.090 |
Why?
|
| Craniosynostoses | 1 | 2013 | 73 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 158 | 0.090 |
Why?
|
| Hippocampus | 1 | 2015 | 459 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2014 | 936 | 0.090 |
Why?
|
| Synaptic Membranes | 1 | 2011 | 14 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 378 | 0.080 |
Why?
|
| X Chromosome Inactivation | 2 | 2009 | 30 | 0.080 |
Why?
|
| Turner Syndrome | 1 | 2010 | 27 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2009 | 303 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2011 | 115 | 0.080 |
Why?
|
| Microsatellite Repeats | 2 | 2008 | 151 | 0.080 |
Why?
|
| Mass Screening | 1 | 2015 | 710 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2005 | 165 | 0.080 |
Why?
|
| Haplotypes | 2 | 2012 | 650 | 0.080 |
Why?
|
| Physicians | 2 | 2015 | 706 | 0.080 |
Why?
|
| De Lange Syndrome | 1 | 2009 | 10 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2005 | 547 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 38 | 0.080 |
Why?
|
| Consumer Advocacy | 1 | 2009 | 10 | 0.080 |
Why?
|
| Pregnancy, High-Risk | 1 | 2009 | 16 | 0.080 |
Why?
|
| Sarcomeres | 1 | 2009 | 27 | 0.080 |
Why?
|
| Parents | 1 | 2012 | 307 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 65 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 76 | 0.070 |
Why?
|
| Medical Informatics | 1 | 2009 | 48 | 0.070 |
Why?
|
| Genotype | 5 | 2017 | 1880 | 0.070 |
Why?
|
| Young Adult | 6 | 2018 | 7026 | 0.070 |
Why?
|
| Microphthalmos | 1 | 2008 | 7 | 0.070 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 12 | 0.070 |
Why?
|
| Limb Deformities, Congenital | 1 | 2008 | 19 | 0.070 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2008 | 11 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 453 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 307 | 0.070 |
Why?
|
| Lod Score | 1 | 2008 | 153 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2005 | 113 | 0.070 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 72 | 0.070 |
Why?
|
| Canada | 2 | 2018 | 214 | 0.070 |
Why?
|
| Pregnancy | 4 | 2012 | 3237 | 0.070 |
Why?
|
| Radiography | 2 | 2000 | 823 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 32 | 0.060 |
Why?
|
| Dystrophin | 1 | 2007 | 25 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 910 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2005 | 358 | 0.060 |
Why?
|
| Diseases in Twins | 1 | 2007 | 65 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 412 | 0.060 |
Why?
|
| Muscular Dystrophies | 1 | 2007 | 55 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 2090 | 0.060 |
Why?
|
| Copper-transporting ATPases | 2 | 2012 | 12 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 82 | 0.060 |
Why?
|
| Homozygote | 3 | 2013 | 208 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2007 | 181 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 247 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2005 | 3106 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2010 | 3040 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 231 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2005 | 422 | 0.060 |
Why?
|
| Proteins | 2 | 2009 | 816 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2017 | 9167 | 0.060 |
Why?
|
| Schools, Medical | 1 | 2006 | 144 | 0.060 |
Why?
|
| Genes, Dominant | 2 | 2005 | 115 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 129 | 0.050 |
Why?
|
| Middle Aged | 6 | 2018 | 28206 | 0.050 |
Why?
|
| Animals | 7 | 2010 | 28889 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 1211 | 0.050 |
Why?
|
| Models, Biological | 2 | 2007 | 1809 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2009 | 681 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2000 | 153 | 0.040 |
Why?
|
| Risk Factors | 2 | 2017 | 5961 | 0.040 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2000 | 9 | 0.040 |
Why?
|
| PrPC Proteins | 1 | 2000 | 13 | 0.040 |
Why?
|
| PrPSc Proteins | 1 | 2000 | 21 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2000 | 67 | 0.040 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2000 | 35 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 95 | 0.040 |
Why?
|
| Family Health | 1 | 2000 | 159 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 1999 | 17 | 0.040 |
Why?
|
| Sex Differentiation | 1 | 1999 | 9 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 1999 | 8 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2000 | 142 | 0.040 |
Why?
|
| Medical Records | 1 | 2000 | 125 | 0.040 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1999 | 19 | 0.040 |
Why?
|
| Prion Diseases | 1 | 1999 | 31 | 0.040 |
Why?
|
| Euchromatin | 1 | 1999 | 6 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 297 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2000 | 165 | 0.040 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1998 | 11 | 0.040 |
Why?
|
| Spine | 1 | 2000 | 153 | 0.040 |
Why?
|
| Propionates | 1 | 1998 | 36 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 1998 | 24 | 0.040 |
Why?
|
| Arm | 1 | 1999 | 100 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 34 | 0.030 |
Why?
|
| Sitosterols | 1 | 2017 | 3 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 35 | 0.030 |
Why?
|
| Exons | 2 | 2012 | 454 | 0.030 |
Why?
|
| Puberty | 1 | 2017 | 60 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 43 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 1999 | 246 | 0.030 |
Why?
|
| Dried Blood Spot Testing | 1 | 2017 | 10 | 0.030 |
Why?
|
| Genetics | 1 | 2017 | 24 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 1999 | 166 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 110 | 0.030 |
Why?
|
| Heart Diseases | 1 | 1999 | 314 | 0.030 |
Why?
|
| Testis | 1 | 2017 | 152 | 0.030 |
Why?
|
| Alleles | 2 | 2013 | 1157 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 1645 | 0.030 |
Why?
|
| Cholesterol | 1 | 2017 | 367 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 1205 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 267 | 0.030 |
Why?
|
| Chromatin | 1 | 1999 | 445 | 0.030 |
Why?
|
| Mice | 2 | 2000 | 12537 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 467 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 2015 | 32 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 10273 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7215 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 1999 | 606 | 0.030 |
Why?
|
| Calibration | 2 | 2005 | 108 | 0.030 |
Why?
|
| Syria | 1 | 2013 | 2 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1349 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 2013 | 53 | 0.030 |
Why?
|
| Pierre Robin Syndrome | 1 | 2013 | 16 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2013 | 27 | 0.030 |
Why?
|
| Germany | 1 | 2013 | 80 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 40 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 58 | 0.020 |
Why?
|
| Zinc Fingers | 2 | 2005 | 60 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 106 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 85 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 1957 | 0.020 |
Why?
|
| North America | 1 | 2013 | 199 | 0.020 |
Why?
|
| Endocardium | 1 | 2013 | 99 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 1714 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 108 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 116 | 0.020 |
Why?
|
| Lysosomes | 1 | 2013 | 124 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 212 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2000 | 1730 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 522 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2012 | 99 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2009 | 747 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 439 | 0.020 |
Why?
|
| Serum Amyloid A Protein | 1 | 1991 | 25 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 263 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 382 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1006 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 706 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1931 | 0.020 |
Why?
|
| Pediatrics | 1 | 2015 | 399 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 1991 | 206 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2010 | 68 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 224 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2009 | 19 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2000 | 3581 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 984 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 256 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1560 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 250 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1319 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 91 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1827 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 5561 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 301 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 57 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 20848 | 0.020 |
Why?
|
| Head | 1 | 2008 | 131 | 0.020 |
Why?
|
| Zebrafish | 1 | 2010 | 342 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 149 | 0.020 |
Why?
|
| Pentosyltransferases | 1 | 2007 | 36 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2009 | 2089 | 0.020 |
Why?
|
| Asparagine | 1 | 2007 | 29 | 0.020 |
Why?
|
| Prognosis | 2 | 2005 | 3990 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 67 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 590 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1127 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2005 | 9 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2005 | 54 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1192 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 548 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2002 | 78 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 109 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2002 | 142 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2342 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 829 | 0.010 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2000 | 14 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2000 | 15 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2039 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2002 | 308 | 0.010 |
Why?
|
| Liver | 2 | 1998 | 1231 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 145 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2000 | 283 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 314 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 394 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 908 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 1156 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 1561 | 0.010 |
Why?
|
| Fingers | 1 | 1998 | 69 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2000 | 777 | 0.010 |
Why?
|
| Calcinosis | 1 | 1998 | 232 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 2536 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 4154 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 1991 | 16 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1991 | 71 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1991 | 103 | 0.010 |
Why?
|
| Cricetinae | 1 | 1991 | 542 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 305 | 0.000 |
Why?
|
| Cytokines | 1 | 1991 | 871 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1991 | 2061 | 0.000 |
Why?
|